4//SEC Filing
Muenchbach Martin 4
Accession 0001142576-07-000012
CIK 0001142576other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 6:49 PM ET
Size
6.0 KB
Accession
0001142576-07-000012
Insider Transaction Report
Form 4
Muenchbach Martin
Director
Transactions
- Award
Common Stock
2007-09-12+2,500→ 2,500 total
Holdings
- 1,025,624(indirect: by BB Biotech Ventures II, L.P.)
Common Stock
Footnotes (1)
- [F1]Dr. Muenchbach is employed as an investment manager at Swissfirst Asset Management AG, which manages BB Biotech Ventures II, L.P.. Dr. Muenchbach disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial owenership of all of the reported shares for purposes of Section 16 or any other purpose.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeother
Related Parties
1- filerCIK 0001380842
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 6:49 PM ET
- Size
- 6.0 KB